{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:03:18Z","timestamp":1767927798297,"version":"3.49.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Community","award":["115336"],"award-info":[{"award-number":["115336"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejps.2017.07.032","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T09:01:33Z","timestamp":1501578093000},"page":"96-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors"],"prefix":"10.1016","volume":"109","author":[{"given":"Shalenie P.","family":"den Braver-Sewradj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel W.","family":"den Braver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Baze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Decorde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Fonsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico P.E.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan N.M.","family":"Commandeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lysiane","family":"Richert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Chris","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.07.032_bb0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tiv.2009.05.021","article-title":"Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions","volume":"24","author":"Abadie-Viollon","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejps.2017.07.032_bb0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdd.1906","article-title":"Protein expression of various hepatic uridine 5\u2032-diphosphate glucuronosyltransferase (UGT) enzymes and their intercorrelations: a meta-analysis","volume":"35","author":"Achour","year":"2014","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0011-2240(02)00011-1","article-title":"Cryopreservation of adult human hepatocytes obtained from resected liver biopsies","volume":"44","author":"Alexandre","year":"2002","journal-title":"Cryobiology"},{"key":"10.1016\/j.ejps.2017.07.032_bb0020","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3109\/00498254.2012.676693","article-title":"Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers","volume":"42","author":"Alexandre","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2017.07.032_bb0025","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-016-9962-6","article-title":"Challenges and opportunities with non-CYP enzymes aldehyde oxidase, carboxylesterase, and UDP-glucuronosyltransferase: focus on reaction phenotyping and prediction of human clearance","author":"Argikar","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2017.07.032_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0014-5793(93)80983-2","article-title":"Latency is the major determinant of UDP-glucuronosyltransferase activity in isolated hepatocytes","volume":"328","author":"B\u00e1nhegyi","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2017.07.032_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bcp.2010.04.034","article-title":"Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels","volume":"80","author":"Bock","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0040","doi-asserted-by":"crossref","first-page":"23529","DOI":"10.1074\/jbc.M303515200","article-title":"Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions","volume":"278","author":"Bod\u00f3","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2017.07.032_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2014.06.015","article-title":"Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds","volume":"83","author":"Bordessa","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2017.07.032_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tiv.2016.02.013","article-title":"Inter-donor variability of phase I\/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer","volume":"33","author":"den Braver-Sewradj","year":"2016","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejps.2017.07.032_bb0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0378-4274(99)00209-X","article-title":"Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases","volume":"112\u2013113","author":"Burchell","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2017.07.032_bb0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0076-6879(05)00003-0","article-title":"Substrate specificity of human hepatic Udp-glucuronosyltransferases","volume":"400","author":"Burchell","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0076-6879(05)00007-8","article-title":"Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases","volume":"400","author":"Court","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425255.2014.876006","article-title":"The role of drug metabolizing enzymes in clearance","volume":"10","author":"Di","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0075","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00216-009-3441-1","article-title":"Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies","volume":"396","author":"Donato","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejps.2017.07.032_bb0080","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1124\/dmd.105.005058","article-title":"Altered AZT (3\u2032-azido-3\u2032-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment","volume":"33","author":"Engtrakul","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tox.2015.02.004","article-title":"Cytotoxicity of phenothiazine derivatives associated with mitochondrial dysfunction: a structure-activity investigation","volume":"330","author":"de Faria","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.ejps.2017.07.032_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-3565(25)10743-X","article-title":"Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine","volume":"262","author":"Frances","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.07.032_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ab.2012.04.031","article-title":"Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography\u2013tandem mass spectrometry","volume":"427","author":"Gagez","year":"2012","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2017.07.032_bb0100","doi-asserted-by":"crossref","first-page":"8648356","DOI":"10.1155\/2016\/8648356","article-title":"Highly synchronized expression of lineage-specific genes during in vitro hepatic differentiation of human pluripotent stem cell lines","volume":"2016","author":"Ghosheh","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.ejps.2017.07.032_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejps.2015.02.001","article-title":"Inhibition screening method of microsomal UGTs using the cocktail approach","volume":"71","author":"Gradinaru","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.07.032_bb0110","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/cbdv.200900102","article-title":"Potentiation of MRP2\/Mrp2-mediated estradiol-17\u03b2-glucuronide transport by drugs - a concise review","volume":"6","author":"Her\u00e9di-Szab\u00f3","year":"2009","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejps.2017.07.032_bb0115","first-page":"570","article-title":"Implications of polymorphic cytochrome p450-dependent drug metabolism for drug development","volume":"29","author":"Ingelman-Sundberg","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/00498254.2014.942810","article-title":"Glucuronidation of fimasartan, a new angiotensin receptor antagonist, is mainly mediated by UGT1A3","volume":"45","author":"Jeong","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2017.07.032_bb0125","doi-asserted-by":"crossref","first-page":"21802","DOI":"10.3390\/molecules201219808","article-title":"In vitro metabolic pathways of the new anti-diabetic drug evogliptin in human liver preparations","volume":"20","author":"Jeong","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2017.07.032_bb0130","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/rcm.7030","article-title":"Screening of six UGT enzyme activities in human liver microsomes using liquid chromatography\/triple quadrupole mass spectrometry","volume":"28","author":"Joo","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ejps.2017.07.032_bb0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/dmd.114.062620","article-title":"A long-standing mystery solved: the formation of 3-hydroxydesloratadine is catalyzed by CYP2C8 but prior glucuronidation of desloratadine by UDP-glucuronosyltransferase 2B10 is an obligatory requirement","volume":"43","author":"Kazmi","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0140","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1124\/dmd.115.065011","article-title":"Further characterization of the metabolism of desloratadine and its cytochrome P450 and UDP-glucuronosyltransferase inhibition potential: identification of desloratadine as a relatively selective UGT2B10 inhibitor","volume":"43","author":"Kazmi","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","article-title":"UDP-glucuronosyltransferases and clinical drug-drug interactions","volume":"106","author":"Kiang","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.07.032_bb0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/clpt.2012.79","article-title":"A perspective on efflux transport proteins in the liver","volume":"92","author":"K\u00f6ck","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.07.032_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.abb.2013.03.012","article-title":"Evaluation of UGT protein interactions in human hepatocytes: effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes","volume":"535","author":"Konopnicki","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejps.2017.07.032_bb0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00498254.2014.945988","article-title":"Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite","volume":"45","author":"Krauser","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2017.07.032_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/taap.1993.1097","article-title":"Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes","volume":"120","author":"Kretz-Rommel","year":"1993","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/rcm.3359","article-title":"A new in vitro approach for the simultaneous determination of phase I and phase II enzymatic activities of human hepatocyte preparations","volume":"22","author":"Lahoz","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ejps.2017.07.032_bb0175","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/dmd.114.063016","article-title":"Simultaneous screening of activities of five cytochrome P450 and four uridine 59-diphospho-glucuronosyltransferase enzymes in human liver microsomes using cocktail incubation and liquid chromatography-tandem mass spectrometry","volume":"43","author":"Lee","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0180","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/0006-2952(92)90225-8","article-title":"Optimal detergent activation of rat liver microsomal UDP-glucuronosyl transferases toward morphine and 1-naphthol: contribution to induction and latency studies","volume":"43","author":"Lett","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0185","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/dmd.113.054528","article-title":"Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition","volume":"42","author":"Lundquist","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.taap.2016.04.009","article-title":"Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases","volume":"301","author":"Lv","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0195","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/dmd.109.031138","article-title":"Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases","volume":"38","author":"Manevski","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0200","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/dmd.106.009969","article-title":"Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes","volume":"34","author":"McGinnity","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.44.101802.121546","article-title":"Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches","volume":"44","author":"Miners","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0210","series-title":"Enzyme-and Transporter-based Drug-drug Interactions","first-page":"217","article-title":"The in vitro characterization of inhibitory drug\u2013drug interactions involving UDP-glucuronosyltransferase","author":"Miners","year":"2010"},{"key":"10.1016\/j.ejps.2017.07.032_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dmpk.2014.10.001","article-title":"Prediction of hepatic and intestinal glucuronidation using in vitro-in vivo extrapolation","volume":"30","author":"Naritomi","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.07.032_bb0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dmpk.2014.12.001","article-title":"A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development","volume":"30","author":"Oda","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.07.032_bb0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.25.16","article-title":"System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes","volume":"25","author":"Parkinson","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.07.032_bb0230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pharmtox-011613-140021","article-title":"Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics","volume":"54","author":"Pfeifer","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/tx500444e","article-title":"Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals","volume":"28","author":"Rendic","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0887-2333(01)00099-6","article-title":"Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes","volume":"16","author":"Richert","year":"2002","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejps.2017.07.032_bb0245","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/dmd.105.007708","article-title":"Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating","volume":"34","author":"Richert","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.toxlet.2016.06.1127","article-title":"Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats","volume":"258","author":"Richert","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2017.07.032_bb0255","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1124\/dmd.114.058818","article-title":"In vitro assay of six UDP-glucuronosyltransferase isoforms in human liver microsomes, using cocktails of probe substrates and liquid chromatography-tandem mass spectrometry","volume":"42","author":"Seo","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0260","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cbi.2009.01.013","article-title":"The extent of phase I and phase II reactions is affected by the choice of enzyme used to prepare rat hepatocytes","volume":"179","author":"Sinclair","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejps.2017.07.032_bb0265","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/jps.23262","article-title":"A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes","volume":"101","author":"Smith","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.07.032_bb0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2125.2003.01721.x","article-title":"A comparison of relative abundance, activity factor and inhibitory monoclonal antibody approaches in the characterization of human CYP enzymology","volume":"55","author":"Soars","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0275","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/dmd.31.6.762","article-title":"The effect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases","volume":"31","author":"Soars","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/dmd.32.1.140","article-title":"An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes","volume":"32","author":"Soars","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpba.2014.03.018","article-title":"A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies","volume":"101","author":"Spaggiari","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2017.07.032_bb0290","series-title":"The 19th International Symposium on Microsomes and Drug Oxidations and 12th European ISSX Meeting","article-title":"Selective conjugation of 7-hydroxycoumarin by recombinant human uridine 5\u2032-diphospho-glucuronosyltransferase (UGT)","author":"Tolando","year":"2012"},{"key":"10.1016\/j.ejps.2017.07.032_bb0295","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.21362","article-title":"Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver","volume":"44","author":"Trottier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2017.07.032_bb0300","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0305","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human UDP-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0310","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2125.2006.02588.x","article-title":"Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation","volume":"61","author":"Uchaipichat","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-2952(84)90375-7","article-title":"Glucuronide formation of various drugs in liver microsomes and in isolated hepatocytes from phenobarbital- and 3-methylcholanthrene-treated rats","volume":"33","author":"Ullrich","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2017.07.032_bb0320","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/dmd.32.3.281","article-title":"Glucuronidation and the UDP-glucuronosyltransferases in health and disease","volume":"32","author":"Wells","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.07.032_bb0325","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrd1851","article-title":"Predicting in vivo drug interactions from in vitro drug discovery data","volume":"4","author":"Wienkers","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2017.07.032_bb0330","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.phrs.2016.05.013","article-title":"Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction","volume":"110","author":"Xu","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2017.07.032_bb0335","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.lfs.2006.08.016","article-title":"The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes","volume":"79","author":"Yao","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2017.07.032_bb0340","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.tiv.2012.01.005","article-title":"Highly variable pH effects on the interaction of diclofenac and indomethacin with human UDP-glucuronosyltransferases","volume":"26","author":"Zhang","year":"2012","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.ejps.2017.07.032_bb0345","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bcpt.12618","article-title":"Human UDP-glucuronosyltransferases 1A1, 1A3, 1A9, 2B4 and 2B7 are inhibited by diethylstilbestrol","volume":"119","author":"Zhu","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717304311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717304311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:32:31Z","timestamp":1750793551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717304311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":69,"alternative-id":["S0928098717304311"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.07.032","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}